Reading exclusive interview | Shenzhen adds "national name" research center. How can small cells make large industries?

"On the basis of Shenzhen's comprehensive industrial chain, with the strong support of the" 20+8 "industrial policy, Shenzhen's cell industry will be promising."

A few days ago, the National Development and Reform Commission officially issued a document approved and agreed to the establishment of the "National Engineering Research Center of the Cell Industry Key Communist Technology", which was led by the Shenzhen Cono Medical Inspection Laboratory. The National Engineering Research Center, which is connected to major market demand ".

In the previous "20+8" industrial policy, the biomedical industry cluster was included in the key cultivation industry, and "cells and genes" have also become one of the key development directions of the eight major future industries.

In this context, what is the significance of the establishment of the "national name" research center? What are the advantages of developing the cell industry in Shenzhen? How should the bottlenecks facing industrial development break through? Dr. Liu Muyun, director of the research center and winner of the National Technology Invention Award, accepted an exclusive interview.

What kind of bottlenecks need to break through our cell industry?

"The global cell industry is entering the era of rapid development. In 2021, it is the harvest year of the cell industry. Whether it is approved by cell products or the activity of investment and financing of the cell industry, this reflects this."

According to Liu Muyun, a total of 6 cell therapy products in the world were approved to be listed in 2021, and two of them were approved in China. The approved products are mainly used to treat diseases such as "malignant tumors" and severe genetic defects. It has brought about the hope of treatment for many patients with "clear diagnosis but not effective".

The Aquelon injection was approved for listing in June 21st, and it was the first cell therapy product to be listed in my country.

In recent years, my country's cell industry has flourished, but as an emerging industry, it still faces some bottleneck problems: First, innovation capabilities need to be improved. Liu Muyun told reporters that there are more than 1,000 companies engaged in the cell industry in my country, but most of them are in the start -up period. The size is small, the product technology is homogeneous, and the source of development and innovation in the source is relatively weak.

Second, instruments and equipment are seriously dependent on imports. From key materials such as medium and cytokines to production instruments and equipment, most of them rely on imports, which is not conducive to the industry's independent innovation, and it is not conducive to high -quality, safe and stable development of the industry.

Third, the distribution of industrial chain is uneven. Due to the low thresholds and technical content of downstream cell therapy and services, the lack of clear access standards, resulting in more crowded employment, entering the low -level homogeneous competition of "cost fighting". The upstream high -end equipment, key core components, cell product research and development and other fields are in a blank state.

This time the National Development and Reform Commission has a forward -looking layout of the cell industry and deployment of the "National Engineering Research Center for key common technology of the cell industry" to solve the above problems.

Why is it Shenzhen?

Why does this "national" cell industry research center choose Shenzhen to land? Liu Muyun said: "Compared with other cities in China, Shenzhen's cell industry has the characteristics of early start, and the industrial chain is relatively complete, especially in the key card points of the industrial chain."

For example, she has the wisdom of the competition of high -end cell equipment upstream in Shenzhen in the upstream and reaches of the industrial chain. In the lower reaches, there are northern traditions focusing on cell therapy services. , my country ’s cell industry talent training and professional title assessment agencies are also in Shenzhen.

Shenzhen Keno Medical Inspection Lab is led by the research center. Picture source: official website of Shenzhen Cono Medical Inspection Laboratory

It is understood that Saiwong Zhizhi delivered the first international automatic cell intelligent manufacturing system, and built a "high -end equipment+modern service" cell industry application demonstration in Shenzhen to create a "new cell intellectual lighthouse factory". "Unmanned 40+ batch of cell products."

The leading unit Ceno Medicine has established the quality standard system, testing service and cell quality traceability inquiry system for the entire life cycle of the cell product, and established "quality standards" and "entry threshold" for the cell product service market.

On the basis of Shenzhen's comprehensive industrial chain, under the strong support of the "20+8" industrial policy, Liu Muyun believes that Shenzhen's cell industry will be promising.

Build 8 major function platforms

Promote the high -quality development of the cell industry

In order to promote the high -quality development of the cell industry and avoid low -level homogeneous competition, the Research Center will build 8 major functional platforms, including new cell and gene therapy technology research and development platform, advanced cell intelligent manufacturing system R & D platform, cell quality monitoring technology research and development platform, and the research and development platform, and the cell quality monitoring technology research and development platform, and the research and development platform of cell quality monitoring technology. CRO R & D Lab, CDMO Intellectual Manufacturing Workshop (Demonstration), Industrial Key Material Research and Development Platform, Cell Periodic Periodic Management Platform, and Industrial Innovation Talent Training Center.

According to reports, the construction and engineering verification platform of common technology research and development of industrial industries will help promote cell preparation from the current labor -intensive, manual operation to fully automatic, fully closed, and continuous unmanned intelligent manufacturing, and effectively improve my country's biomedical industry International Competitiveness.

"The research center will create a cell industry innovation service platform that integrates 'entrepreneurial incubation, research and development, advanced intelligence manufacturing, technology test, and quality testing'." Liu Muyun said that after the platform is completed, it will accelerate the key core technology of my country's cell industry Autonomous and controllable with high -end cell intellectual equipment, strengthen the security and stability of the industrial chain and supply chain, and promote the high -quality development of my country's cell industry.

Reprinting needs to indicate the author and source reading special client

(Author: Reading reporter Yan Yan)

- END -